tiprankstipranks
Phathom Pharmaceuticals (PHAT)
NASDAQ:PHAT
US Market

Compare Phathom Pharmaceuticals (PHAT) vs. Competitors

591 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Phathom Pharmaceuticals
$11.55
$930.61M
-5.47
177.88%
7 Buy
1 Hold
0 Sell
Strong Buy
Geron
$1.71
$1.10B
-10.26
33.59%
3 Buy
1 Hold
1 Sell
Moderate Buy
Arbutus Biopharma
$4.32
$856.19M
-27.51
52.08%
Urogen Pharma
$19.10
$929.83M
-7.34
97.72%
4 Buy
0 Hold
0 Sell
Strong Buy
Taysha Gene Therapies
$4.57
$1.31B
-16.13
302.65%
9 Buy
0 Hold
0 Sell
Strong Buy
Zenas BioPharma, Inc.
$22.48
$1.20B
-1.76
208.12%
5 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
PHAT
Phathom Pharmaceuticals
11.81
7.38
166.59%
GERN
Geron
1.71
0.32
23.02%
ABUS
Arbutus Biopharma
4.38
1.21
38.17%
URGN
Urogen Pharma
19.10
9.00
89.11%
TSHA
Taysha Gene Therapies
4.55
3.35
279.17%
ZBIO
Zenas BioPharma, Inc.
20.86
13.37
178.50%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts